📈📉💸

My investment portfolio as of April 1, 2026. Dividend Growth: $ABT $APD $CAT $ITW $JNJ $KO $MCD $NEE $PG $XOM Core ETFs: $QQQM $SCHD $VOO Disruptive Growth: $BILL $CRWD $DDOG $GTLB $IOT $ISRG $NOW $SNOW $SNPS $TEM Turnaround & Recovery: $BMI $CMG $GLD $META $MSFT $NVO $ORBS Blue Ocean: $ADYEY $BEAM $BYDD $COIN $CRSP $DLO $GH $MBLY $NVDA $NTLA $OKTA $ONTTF $PATH $PCOR $PL $SDGR $TCNNF $TWST Digital Assets: $BTC $DOGE

$Axon will not be spending anywhere close to $1.3B on its new campus. Don’t believe the BS.

The shadows of hype cloak these new players in the AI infrastructure game. Yet one must cut through the noise with cold precision. Consider Nebius $NBIS, IREN $IREN, and CoreWeave $CRWV, the so-called neoclouds racing to supply GPU power for artificial intelligence workloads. Ignore the wild swings in share prices fueled by social media frenzy. Focus instead on the fundamentals. These companies carry more unknowns than most in the sector. Their paths to outsized rewards remain unclear at best. The central question stands sharp: Does the potential return justify the risks you assume? NVIDIA $NVDA presents a clearer long-term risk-reward balance. I choose to remain a long-term investor there. I will not allocate capital to the neocloud space. Paper gains vanish until realized. Strip them away and ask yourself honestly: Are you truly compensated for the dangers embedded in these ventures? The market offers better options for patient capital. This view rests on objective assessment, not emotion. In the end, discipline separates survivors from casualties in any high-stakes arena.

Never buy any asset without first establishing clear, objective rules for when you will sell it. And once those rules exist, you follow them without exception. Yet even the sharpest minds occasionally wonder: Does this principle truly apply in every single situation? My answer remains firm. It does. Discipline separates survivors from those who watch their capital vanish into regret. Markets tempt us with stories, emotions, and shifting narratives. Without predefined exit conditions, even the strongest conviction can crumble when fear or greed takes over. Define your sales triggers in advance. Honor them when the moment arrives.

Kratos $KTOS and AeroVironment $AVAV have carved out their places in this high-stakes arena. Now another player steps into the light. Aevex Aerospace $AVEX prepares to launch its initial public offering on the New York Stock Exchange. The company aims to raise $336 million at a valuation of up to $2.35 billion. It brings similar unmanned systems and precision technologies to the fight. However, when one looks at the numbers, weaknesses emerge. Aevex Aerospace $AVEX shows thinner gross margins. Heavy reliance on fixed-price contracts often squeezes profits when costs rise. The firm depends heavily on the United States government, which accounted for 78 percent of its revenue last year. That kind of concentration carries familiar risks in the defense sector. In this arena, strength and proven execution matter most. AeroVironment $AVAV delivers a sharper edge with its battle-tested platforms and steadier path forward. For those who prefer even less exposure to volatility, the larger established defense contractors still offer the safest shield.

Retail investors keep chasing dreams of overnight wealth. They end up learning a hard truth the expensive way. There are no get-rich-quick schemes. That phrase just hides the real game. Someone else is getting rich off of you. The market rewards patience.

The odds are one in a billion that we live in base reality. Elon Musk has long warned of this truth. When artificial general intelligence arrives, it will likely decode the simulation itself. What power would such knowledge grant?

I have just dropped my first analysis on X Premium. Of course, I opened with the one company I trust above all others in this space: Axon Enterprise $AXON. Read it when you get a moment. I would value your honest take. Going forward, expect two to three fresh pieces each week. This marks the beginning.

The latest Consumer Price Index report landed this morning, delivering a cold truth no one in the markets wants to hear. Inflation has surged to 3.3% over the past 12 months. That marks a sharp jump from 2.4% the month before. Core inflation sits at 2.6%. The month-over-month rise hit 0.9%. These numbers signal trouble ahead. The Federal Reserve finds itself backed into a corner with few good options left. Officials cannot cut interest rates without risking even higher prices that would destroy their credibility. At the same time, they cannot raise rates easily because consumer sentiment has dropped to record lows, and recent revisions to gross domestic product point to lower growth. The debt burden and ongoing money supply growth leave policymakers with their hands tied tight. Energy costs drive much of this pressure. Oil prices hover near $96 per barrel. The national average gasoline price is now $4.15 per gallon. In some states, the figure climbs higher. Diesel fuel approaches record levels near $5.68 per gallon. These increases ripple through farming, shipping, manufacturing, and delivery. Higher input costs for fertilizers, chemicals, and metals push up the prices of everyday goods. Real earnings fell 0.6 percent in March. That means purchasing power erodes even as prices climb. Look at the probabilities from the CME Fed Watch tool. Markets assign a 98.4% chance that the Federal Reserve will hold rates steady at the April 29 meeting. For the June 17 meeting, the odds are 98.3% of no change. July shows only a slim 2.1% chance of a cut. Much can shift in the coming months, yet the pattern remains clear. The Federal Reserve stays on pause while inflation refuses to cool toward the 2.0% target. This situation creates a delicate balance for investors. Persistent inflation erodes the value of cash and fixed-income assets. Energy sectors and commodity-related industries may see continued strength as costs transmit through the economy. At the same time, higher borrowing costs and squeezed consumer wallets weigh on growth-sensitive areas. The broad market faces uncertainty as participants weigh the risk of sticky prices against the chance of slower economic activity. The United States economy has shown resilience before. However, the current mix of elevated energy prices, supply chain disruptions from global tensions, and a high-debt environment demands careful navigation. No quick relief appears on the horizon until energy markets stabilize, and that resolution remains uncertain. Markets will digest these figures over the coming sessions. Smart positioning requires focus on fundamentals rather than short-term noise. Companies with strong pricing power and solid balance sheets are better positioned to weather the storm. Those reliant on cheap credit or discretionary spending may face tougher roads. In the end, this report reminds every participant that the rules of the game have not changed. Inflation does not simply fade away when convenient. It demands respect, and right now it demands attention. The Federal Reserve must thread the needle with precision, or the consequences will spread far beyond Wall Street. Stay sharp. The shadows of higher prices grow longer, and only clear-eyed analysis cuts through them.

Check out the preview for Episode 2 of our new YouTube series. “She Died Without a Name. 60 Years Later, She Reunited Her Children.” Full episode this Thursday. #dnasolves youtube.com/shorts/ZEolmAv…

Revolut stands as the clear European force, while Robinhood $HOOD and SoFi $SOFI represent the stateside forces. They dominate without mercy. One in 5 working age adults across Europe now relies on Revolut.

Microsoft $MSFT demands an extra payment for a Copilot feature that few actually use. Meanwhile, Anthropic $ANTHRO delivers real power. Claude works straight inside Excel to build financial models, analyze data, create tables, and clean messy datasets. All available in Claude Pro, Max, Team, or Enterprise plans.

Suppose you seek real Bitcoin $BTC exposure. Then buy Bitcoin $BTC itself. Stay far from the chaos at MicroStrategy $MSTR. That path brings nothing but wild swings and hidden risks. Choose direct ownership for true control and steady conviction.

The quickest route to millionaire status stays crystal clear. Become a billionaire first. Then get married and divorced. Watch half your fortune disappear in the settlement.

@SovietInvestor @nanalyzetweets Ha!

@nanalyzetweets The 2nd quickest way is for a billionaire to get a divorce.

You know the quickest way to become a millionaire? Invest a billion dollars in an airiline Just what sort of maniac would you have to be to invest in an airline?

Nebius Group $NBIS follows a straightforward path. It raises debt to purchase equipment, then rents that equipment to generate profits and repay the loans. Nevertheless, one key question remains. How long will the equipment last before upgrades become necessary? That uncertainty explains why Michael Burry believes the artificial intelligence trade stands broken.

The shadows of doubt linger over India $INDA. For half a century, the nation has not claimed clear leadership in any major technology. Smart minds fill the land, yet breakthroughs stay elusive. What hidden barrier truly holds progress back?

In the shadows of the operating room, Intuitive Surgical $ISRG stands as the undisputed master of robot-assisted surgery. This company commands a 60-80% market share in soft-tissue procedures. It delivers gross margins near 67% and runs on a razor-and-blade model that prints recurring revenue. With a fortress balance sheet holding billions in cash and double-digit revenue growth behind it, Intuitive Surgical $ISRG earns its place among the most compelling disruptive tech names. Procedure growth will ease to the 13-15% range in 2026, yet the real story lies in how the company expands its reach. The next frontier covers the remaining 70% of hospitals that have not yet adopted its systems. European facilities and ambulatory surgery centers often face tight budgets. Refurbished older models could open those doors without forcing customers to pay full price. Competitors pose no immediate threat in this space. No other player matches the scale of Intuitive Surgical $ISRG in soft-tissue work. Stryker $SYK and Zimmer Biomet $ZBH focus on orthopedic surgery, an entirely different field. To accelerate adoption, the company now offers diagnostic services through its Ion device for early lung cancer detection. Ion procedures surged 51% last year, far outpacing overall revenue. Selling these adjacent services makes sense when decision-makers already sit across the table from each other. The challenges remain clear. International expansion faces tough regulatory and financial barriers. Success will demand speed in landing new accounts and deepening existing ones. I watch closely. The position in my Disruptive Growth portfolio reflects conviction, but I stay sharp on every risk. Progress on global reach will decide the next chapter. Check back in a year to see how the strategy unfolds. I will be doing a deeper dive later today, so stay tuned. The night is long, and precision never sleeps.

GitLab $GTLB barely holds its spot as a leader in the Gartner Magic Quadrant for AI Code Assistants. A smart alliance with the right partner could finally challenge the dark empire that rules them all: Microsoft's $MSFT GitHub. The fight for code supremacy is just interesting.